American Library at NaUKMA : 01.01.19

ÐšÐ°Ñ€Ñ‚Ð¸Ð½ÐºÐ¸ Ð¿Ð¾ Ð·Ð°Ð¿Ñ€Ð¾ÑÑƒ wear red day 2019

This year we will mark Wear Red Day on February the 1st.

On this day we raise awareness about congenital heart disease. Look at the bibliography of works dedicated to this topic. These materials can be found on eLibraryUSA platform in the JSTOR database

JSTOR

Anderson, Ian M. “Survival In Severe Congenital Heart Disease.” Vol. 3, no. 5767, 1971, pp. 184–184. JSTOR, www.jstor.org.vlib.interchange.at/stable/25415207. Accessed 29 Jan. 2019.

Celermajer, David S., and John E. Deanfield. “Adults With Congenital Heart Disease: A Comprehensive Specialist Service Is Needed.” Vol. 303, no. 6815, 1991, pp. 1413–1414., www.jstor.org.vlib.interchange.at/stable/29713887. Accessed 29 Jan. 2019.

“Congenital Heart Disease.” Vol. 2, no. 4681, 1950, pp. 717–718. JSTOR, www.jstor.org.vlib.interchange.at/stable/25358462. Accessed 29 Jan. 2019.

“Erratum: Birth Prevalence of Congenital Heart Disease.” Vol. 20, no. 4, 2009, pp. 630–630., www.jstor.org.vlib.interchange.at/stable/25662723. Accessed 29 Jan. 2019.

Floquet, P., et al. “The Psychosocial Adaptability of Adolescents with Congenital Heart Disease.” Vol. 6, no. 7/8, 1997, pp. 645–646. JSTOR, www.jstor.org.vlib.interchange.at/stable/4035464. Accessed 29 Jan. 2019.

“Genetics Of Congenital Heart Disease.” Vol. 1, no. 4924, 1955, pp. 1268–1268. JSTOR, www.jstor.org.vlib.interchange.at/stable/20363664. Accessed 29 Jan. 2019.

Goodwin, J. F., and Alden S. Gooch. “Teaching About Congenital Heart Disease.” Vol. 2, no. 5707, 1970, pp. 474–474. JSTOR, www.jstor.org.vlib.interchange.at/stable/20383830. Accessed 29 Jan. 2019.

“Heredity And Congenital Heart Disease.” Vol. 1, no. 5123, 1959, pp. 704–705. JSTOR, www.jstor.org.vlib.interchange.at/stable/25386897. Accessed 29 Jan. 2019.

Hollman, A., and Joseph K. Perloff. “Congenital Heart Disease.” Vol. 1, no. 5794, 1972, pp. 258–258. JSTOR, www.jstor.org.vlib.interchange.at/stable/25417468. Accessed 29 Jan. 2019.

Insley, Jack. “The Heritability Of Congenital Heart Disease.” Vol. 294, no. 6573, 1987, pp. 662–663. JSTOR, www.jstor.org.vlib.interchange.at/stable/29526353. Accessed 29 Jan. 2019.

Johnson, A. M. “Congenital Heart Disease.” Vol. 1, no. 5594, 1968, pp. 764–764. JSTOR, www.jstor.org.vlib.interchange.at/stable/20391958. Accessed 29 Jan. 2019.

Kinnersley, Paul, et al. “Detecting Congenital Heart Disease Prenatally.” Vol. 304, no. 6833, 1992, pp. 1055–1055., www.jstor.org.vlib.interchange.at/stable/29715306. Accessed 29 Jan. 2019.

Muir, D. C., and J. W. Brown. “Congenital Heart Disease.” Vol. 1, no. 3879, 1935, pp. 966–971. JSTOR, www.jstor.org.vlib.interchange.at/stable/25344119. Accessed 29 Jan. 2019.

Olsen, E. G. J., et al. “Cardiological Problems Simplified.” Vol. 284, no. 6320, 1982, pp. 967–968. JSTOR, www.jstor.org.vlib.interchange.at/stable/29505818. Accessed 29 Jan. 2019.

Scott, Olive. “Survival In Severe Congenital Heart Disease.” Vol. 3, no. 5777, 1971, pp. 769–769. JSTOR, www.jstor.org.vlib.interchange.at/stable/25416000. Accessed 29 Jan. 2019.

“Symposium On Congenital Heart Disease.” Vol. 2, no. 5528, 1966, pp. 1519–1520. JSTOR, www.jstor.org.vlib.interchange.at/stable/25410437. Accessed 29 Jan. 2019.

Tubman, T. R. J., et al. “Congenital Heart Disease In Down's Syndrome: Two Year Prospective Early Screening Study.” Vol. 302, no. 6790, 1991, pp. 1425–1427., www.jstor.org.vlib.interchange.at/stable/29711906. Accessed 29 Jan. 2019. Objective—To determine the effectiveness of clinical examination, chest radiography, and electrocardiography compared with echocardiography in detecting congenital heart disease early in the life of children with Down's syndrome. Design—Prospective two year screening survey. Setting—Regional paediatric cardiology service, Northern Ireland. Patients—81 newborn infants with Down's syndrome born in Northern Ireland between November 1987 and November 1989. Interventions—Clinical examination, chest radiography, and electrocardiography soon after birth followed by cross sectional Doppler echocardiography. Main outcome measures—Diagnostic ability of clinical examination, radiography, and electrocardiography compared with echocardiographic findings. Results—34 babies had congenital heart disease detected by echocardiography (13 had atrioventricular septal defects, seven secundum atrial septal defects, six a solitary patent ductus arteriosus, five isolated ventricular septal defects, and three combinations of heart defects). Individual examination methods were insensitive (the sensitivity of clinical examination was 0.53, of radiography 0.44, and of electrocardiography 0.41) but highly specific (the specificity of clinical examination was 0.94, of radiography 0.98, and of electrocardiography 1.0), although sensitivity improved when the three techniques were combined (the sensitivity was 0.71, the specificity 0.91). Conclusion—Echocardiography performed early in life can detect congenital heart disease that might otherwise be missed. Early detection may help prevent complications such as pulmonary vascular disease that may adversely affect the outcome of cardiac surgery.

Uebing, Anselm, et al. “Pregnancy And Congenital Heart Disease.” Vol. 332, no. 7538, 2006, pp. 401–406., www.jstor.org.vlib.interchange.at/stable/25456163. Accessed 29 Jan. 2019.

Velde, E. T. Vander, et al. “CONCOR, an Initiative towards a National Registry and DNA-Bank of Patients with Congenital Heart Disease in the Netherlands: Rationale, Design, and First Results.” Vol. 20, no. 6, 2005, pp. 549–557. JSTOR, www.jstor.org.vlib.interchange.at/stable/25047491. Accessed 29 Jan. 2019. [Introduction: Survival of patients with congenital heart disease has dramatically improved after surgical repair became available 40 years ago. Instead of a mortality of 85% during childhood following the natural course, over 85% of these infants are now expected to reach adulthood. However, data on long-term outcome is scarce due to the lack of large, national registries. Moreover, little is known about the genetic basis of congenital heart defects. In 2000, the Interuniversity Cardiology Institute of the Netherlands and the Netherlands Heart Foundation have taken the initiative to develop a national registry and DNA-bank of patients with congenital heart disease in the Netherlands named CONCOR. Objectives: The aims of the CONCOR project are to facilitate investigation of the prevalence and long-term outcome of specific congenital heart defects and their treatment, to develop an efficient organisational structure for the improvement of healthcare for patients with congenital heart disease, and to allow investigation of the molecular basis of congenital heart defects. Methods: After informed consent, research nurses enter data of participating patients into the CONCOR database using a web application. Data is transferred over the Internet via a secure connection. About 20 ml blood is withdrawn from the patient, and the DNA is isolated and stored. From each participating patient family history on congenital heart disease is obtained. Results: Within two and a half years more than 4200 patients have agreed to participate. More than 99% of the patients that were asked have given their consent to participate in CONCOR. From 60% of these patients DNA has already been obtained. Mean age of the patients included is 34 years; more than 85% of the patients are younger than 45 years. Late complications occur frequently and the incidence increases with advancing age. 18% of the patients are known with supraventricular or ventricular arrhythmias. 2% of the included patients suffered a cerebrovascular accident, 139 (3%) had endocarditis. 6% of the patients has pulmonary hypertension or Eisenmenger syndrome. More than 15% of the patients reported an affected family member with congenital heart disease in the first, second, or third degree. 6% has an affected first-degree relative, and 4% a second-degree relative. Already 10 research projects have started using the CONCOR data and DNA. Conclusion: The population of patients with congenital heart disease is young and rapidly growing. Late complications occur frequently and the incidence increases with advances age. The CONCOR registry and DNA-bank facilitates research on prevalence and long-term outcome and allows investigation of the molecular basis of congenital heart disease.]

Zhan, S. Y., et al. “Effect of Fathers' Age and Birth Order on Occurrence of Congenital Heart Disease.” Vol. 45, no. 4, 1991, pp. 299–301. JSTOR, www.jstor.org.vlib.interchange.at/stable/25567218. Accessed 29 Jan. 2019. [Study objective-The aim was to examine if there is an effect of fathers' age and of birth order on the occurrence of congenital heart disease. Design-This was a hospital based case-referent study including use of birth defects surveillance data. Subjects-Subjects were 497 cases of congenital heart disease aged between 3 months and 5 years, born in Beijing and Hebei Province, China; 6222 children without congenital heart disease serve as reference baseline. Measurements and main results-With stratified analysis and logistic regression analyses, congenital heart disease was found to be associated with fathers' age < 25 years (odds ratio 2·63), independent of mothers' age and of birth order. There was also evidence to show a higher birth order effect on the occurrence of congenital heart disease independent of parental ages. Conclusion-Higher birth order and fathers aged < 25 years were both independently associated with some categories of congenital heart disease and with congenital heart disease overall.]